LTIP608A - Peptide compounds, method for the preparation and use thereof - Google Patents

Peptide compounds, method for the preparation and use thereof

Info

Publication number
LTIP608A
LTIP608A LTIP608A LTIP608A LTIP608A LT IP608 A LTIP608 A LT IP608A LT IP608 A LTIP608 A LT IP608A LT IP608 A LTIP608 A LT IP608A LT IP608 A LTIP608 A LT IP608A
Authority
LT
Lithuania
Prior art keywords
preparation
peptide compounds
peptide
compounds
Prior art date
Application number
LTIP608A
Inventor
Kjell Undheim
Peter Kremminger
Michael Hartmann
Original Assignee
Hafslund Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed As filed Critical Hafslund Nycomed As
Publication of LTIP608A publication Critical patent/LTIP608A/en
Publication of LT3615B publication Critical patent/LT3615B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTIP608A 1992-06-02 1993-06-02 Peptide compounds, method for the preparation and use thereof LT3615B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211668A GB9211668D0 (en) 1992-06-02 1992-06-02 Peptide compounds

Publications (2)

Publication Number Publication Date
LTIP608A true LTIP608A (en) 1995-01-31
LT3615B LT3615B (en) 1995-12-27

Family

ID=10716403

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP608A LT3615B (en) 1992-06-02 1993-06-02 Peptide compounds, method for the preparation and use thereof

Country Status (13)

Country Link
US (1) US5629293A (en)
EP (1) EP0643725A1 (en)
JP (1) JPH08501067A (en)
CN (1) CN1085912A (en)
AU (1) AU4340493A (en)
EE (1) EE03101B1 (en)
GB (1) GB9211668D0 (en)
LT (1) LT3615B (en)
LV (1) LV10287B (en)
NO (1) NO944670L (en)
TW (1) TW329427B (en)
WO (1) WO1993024524A1 (en)
ZA (1) ZA933866B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
US6908899B2 (en) * 2001-08-17 2005-06-21 U.S. Dept. Of Veterans Affairs Pro-inflammatory fibrinopeptide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
FI77875C (en) 1982-11-26 1989-05-10 Nyegaard & Co As FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA PEPTIDER.
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
FR2567524B1 (en) * 1984-07-10 1987-11-27 Sanofi Sa PROCESS FOR THE SYNTHESIS OF SOMATOCRININ IN LIQUID PHASE AND INTERMEDIATE PEPTIDES
ZA846192B (en) * 1984-08-09 1986-03-26 Merck Patent Gmbh Immunotherapeutic polypeptide agents
GB8626539D0 (en) 1986-11-06 1986-12-10 Nycomed As Peptide compounds
GB8630721D0 (en) * 1986-12-23 1987-02-04 Unilever Plc Cosmetic compositions
GB8821785D0 (en) * 1988-09-16 1988-10-19 Nycomed As Peptide compounds
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides
ZW11290A1 (en) 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
TW222280B (en) * 1991-11-26 1994-04-11 Smithkline Beecham Corp

Also Published As

Publication number Publication date
NO944670D0 (en) 1994-12-02
TW329427B (en) 1998-04-11
LV10287A (en) 1994-10-20
AU4340493A (en) 1993-12-30
LT3615B (en) 1995-12-27
US5629293A (en) 1997-05-13
WO1993024524A1 (en) 1993-12-09
ZA933866B (en) 1994-06-14
EE03101B1 (en) 1998-06-15
JPH08501067A (en) 1996-02-06
LV10287B (en) 1995-04-20
NO944670L (en) 1995-01-19
EP0643725A1 (en) 1995-03-22
CN1085912A (en) 1994-04-27
GB9211668D0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
GB9113219D0 (en) Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
IL106600A0 (en) Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof
EP0578819A4 (en) Icam-related protein.
IL109437A0 (en) 2-Amino-4-quinolyldihydropyridines, processes for their preparation and their use
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
EP0890599A4 (en) Polyorganosiloxazanes and process for the preparation thereof
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
EP0603965A3 (en) Modified block copolymers and process for the preparation thereof.
IL103142A0 (en) Substituted aminopropanes,processes for their preparation,and their use
LTIP606A (en) Peptide compounds, method for the preparation and use thereof
IL111707A0 (en) Substituted benzimidazole, processes for its preparation and its pharmaceutical use
HRP930131A2 (en) Amino-ascorbic acid derivatives, process for the preparation and use thereof
EP0542217A3 (en) Substituted 1,5-pentanediols and processes for the preparation thereof
LTIP608A (en) Peptide compounds, method for the preparation and use thereof
ZA933848B (en) Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
IL116967A (en) Ethyl-6-formyloxy-4-hexenoate and process for the preparation thereof
OA09875A (en) Deep-drilling cement and process for the preparation thereof
ZA933815B (en) Pyrimidinyl- and triazinyl-salicyl- and -picolyl- amides and the use and preparation thereof.
LTIP607A (en) Peptide compounds, method for the preparation and use thereof
EP0597810A3 (en) Epithelium-tubular carrier biostructure and method for the preparation thereof.
ZA935346B (en) Diazabicycloalkenes and processes for the preparation thereof
EP0738707A3 (en) Dianilinoglutacondialdehyde compound and process for the preparation thereof
HUP9601520A3 (en) Substituted quinoline-intermediates and process for preparation the same
HUP9601521A2 (en) Substituted quinoline-intermediates and process for preparation the same
GB9213013D0 (en) Pharmaceutical preparation based on tretinon

Legal Events

Date Code Title Description
PC9A Transfer of patents

Free format text: NYCOMED IMAGING AS,NYCOVEIEN 1-2, N-0401 OSLO 4,NO,19961106

PD9A Change of patent owner

Free format text: NYCOMED IMAGING AS,NYCOVEIEN 1-2, N-0401 OSLO 4,NO,19961106,

MM9A Lapsed patents

Effective date: 19990602